BVS Q1 2016 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$581M

Q1 2016 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$65M+22.6% YoY

Gross Profit

$46M70.6% margin

Operating Income

-$2M-3.1% margin

Net Income

-$6M-9.2% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$486M

Total Liabilities

$300M

Stockholders' Equity

$186M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$53M	+22.6%
Gross Profit	$46M	$37M	+26.3%
Operating Income	-$2M	-$16M	+87.5%
Net Income	-$6M	-$21M	+71.2%